These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 17015053

  • 1. SLCO1B1 polymorphism and sex affect the pharmacokinetics of pravastatin but not fluvastatin.
    Niemi M, Pasanen MK, Neuvonen PJ.
    Clin Pharmacol Ther; 2006 Oct; 80(4):356-66. PubMed ID: 17015053
    [Abstract] [Full Text] [Related]

  • 2. The effect of SLCO1B1*15 on the disposition of pravastatin and pitavastatin is substrate dependent: the contribution of transporting activity changes by SLCO1B1*15.
    Deng JW, Song IS, Shin HJ, Yeo CW, Cho DY, Shon JH, Shin JG.
    Pharmacogenet Genomics; 2008 May; 18(5):424-33. PubMed ID: 18408565
    [Abstract] [Full Text] [Related]

  • 3. No significant effect of SLCO1B1 polymorphism on the pharmacokinetics of rosiglitazone and pioglitazone.
    Kalliokoski A, Neuvonen M, Neuvonen PJ, Niemi M.
    Br J Clin Pharmacol; 2008 Jan; 65(1):78-86. PubMed ID: 17635496
    [Abstract] [Full Text] [Related]

  • 4. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid.
    Pasanen MK, Neuvonen M, Neuvonen PJ, Niemi M.
    Pharmacogenet Genomics; 2006 Dec; 16(12):873-9. PubMed ID: 17108811
    [Abstract] [Full Text] [Related]

  • 5. Different effects of the ABCG2 c.421C>A SNP on the pharmacokinetics of fluvastatin, pravastatin and simvastatin.
    Keskitalo JE, Pasanen MK, Neuvonen PJ, Niemi M.
    Pharmacogenomics; 2009 Oct; 10(10):1617-24. PubMed ID: 19842935
    [Abstract] [Full Text] [Related]

  • 6. Impact of the SLCO1B1 polymorphism on the pharmacokinetics and lipid-lowering efficacy of multiple-dose pravastatin.
    Igel M, Arnold KA, Niemi M, Hofmann U, Schwab M, Lütjohann D, von Bergmann K, Eichelbaum M, Kivistö KT.
    Clin Pharmacol Ther; 2006 May; 79(5):419-26. PubMed ID: 16678544
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes.
    Hedman M, Antikainen M, Holmberg C, Neuvonen M, Eichelbaum M, Kivistö KT, Neuvonen PJ, Niemi M.
    Br J Clin Pharmacol; 2006 Jun; 61(6):706-15. PubMed ID: 16722833
    [Abstract] [Full Text] [Related]

  • 8. Effect of SLCO1B1 polymorphism on the plasma concentrations of bile acids and bile acid synthesis marker in humans.
    Xiang X, Han Y, Neuvonen M, Pasanen MK, Kalliokoski A, Backman JT, Laitila J, Neuvonen PJ, Niemi M.
    Pharmacogenet Genomics; 2009 Jun; 19(6):447-57. PubMed ID: 19387419
    [Abstract] [Full Text] [Related]

  • 9. Polymorphism of the hepatic influx transporter organic anion transporting polypeptide 1B1 is associated with increased cholesterol synthesis rate.
    Pasanen MK, Miettinen TA, Gylling H, Neuvonen PJ, Niemi M.
    Pharmacogenet Genomics; 2008 Oct; 18(10):921-6. PubMed ID: 18794729
    [Abstract] [Full Text] [Related]

  • 10. Effects of organic anion transporting polypeptide 1B1 haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril.
    Maeda K, Ieiri I, Yasuda K, Fujino A, Fujiwara H, Otsubo K, Hirano M, Watanabe T, Kitamura Y, Kusuhara H, Sugiyama Y.
    Clin Pharmacol Ther; 2006 May; 79(5):427-39. PubMed ID: 16678545
    [Abstract] [Full Text] [Related]

  • 11. No significant effect of ABCB1 haplotypes on the pharmacokinetics of fluvastatin, pravastatin, lovastatin, and rosuvastatin.
    Keskitalo JE, Kurkinen KJ, Neuvonen M, Backman JT, Neuvonen PJ, Niemi M.
    Br J Clin Pharmacol; 2009 Aug; 68(2):207-13. PubMed ID: 19694740
    [Abstract] [Full Text] [Related]

  • 12. Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans.
    Kivistö KT, Niemi M.
    Pharm Res; 2007 Feb; 24(2):239-47. PubMed ID: 17177112
    [Abstract] [Full Text] [Related]

  • 13. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
    Daka A, Dimovski A, Kapedanovska A, Vavlukis M, Eftimov A, Labachevski N, Jakjovski K, Geshkovska MN, Nebija D, Mladenovska K.
    Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
    [Abstract] [Full Text] [Related]

  • 14. The effect of SLCO1B1 polymorphism on repaglinide pharmacokinetics persists over a wide dose range.
    Kalliokoski A, Neuvonen M, Neuvonen PJ, Niemi M.
    Br J Clin Pharmacol; 2008 Dec; 66(6):818-25. PubMed ID: 18823304
    [Abstract] [Full Text] [Related]

  • 15. Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics.
    Niemi M, Backman JT, Kajosaari LI, Leathart JB, Neuvonen M, Daly AK, Eichelbaum M, Kivistö KT, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 Jun; 77(6):468-78. PubMed ID: 15961978
    [Abstract] [Full Text] [Related]

  • 16. Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism.
    He YJ, Zhang W, Chen Y, Guo D, Tu JH, Xu LY, Tan ZR, Chen BL, Li Z, Zhou G, Yu BN, Kirchheiner J, Zhou HH.
    Clin Chim Acta; 2009 Jul; 405(1-2):49-52. PubMed ID: 19374892
    [Abstract] [Full Text] [Related]

  • 17. Different effects of SLCO1B1 polymorphism on the pharmacokinetics and pharmacodynamics of repaglinide and nateglinide.
    Kalliokoski A, Neuvonen M, Neuvonen PJ, Niemi M.
    J Clin Pharmacol; 2008 Mar; 48(3):311-21. PubMed ID: 18187595
    [Abstract] [Full Text] [Related]

  • 18. Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin.
    Aquilante CL, Kiser JJ, Anderson PL, Christians U, Kosmiski LA, Daily EB, Hoffman KL, Hopley CW, Predhomme JA, Schniedewind B, Sidhom MS.
    J Clin Pharmacol; 2012 Nov; 52(11):1725-38. PubMed ID: 22174437
    [Abstract] [Full Text] [Related]

  • 19. CYP2C9*3(1075A > C), ABCB1 and SLCO1B1 genetic polymorphisms and gender are determinants of inter-subject variability in pitavastatin pharmacokinetics.
    Zhou Q, Chen QX, Ruan ZR, Yuan H, Xu HM, Zeng S.
    Pharmazie; 2013 Mar; 68(3):187-94. PubMed ID: 23556337
    [Abstract] [Full Text] [Related]

  • 20. Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin.
    Pasanen MK, Fredrikson H, Neuvonen PJ, Niemi M.
    Clin Pharmacol Ther; 2007 Dec; 82(6):726-33. PubMed ID: 17473846
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.